BJA FY25 Harold Rogers Prescription Drug Monitoring Program Training and Technical Assistance Program

The BJA FY25 Harold Rogers Prescription Drug Monitoring Program Training and Technical Assistance Program seeks to support the development, enhancement, and implementation of Prescription Drug Monitoring Programs (PDMPs) to address the misuse and diversion of controlled substances such as opioids. This funding opportunity, managed by the Bureau of Justice Assistance under the U.S. Department of Justice, provides resources to deliver technical assistance and training to state and territory PDMP administrators and practitioners. A single award of up to $6,000,000 will be granted, with a performance period of 24 months starting October 1, 2025. The program aims to strengthen PDMPs by improving data quality, expanding collection capabilities, and promoting the integration of PDMP data with other systems, such as health information exchanges and electronic health records. Additionally, the program focuses on enhancing data sharing across jurisdictions, enabling the use of advanced analytics to inform prevention and intervention strategies, and fostering collaboration among stakeholders in public health, law enforcement, and the healthcare sector. Eligible applicants include educational institutions, nonprofit organizations, for-profit entities, and small businesses capable of providing technical assistance and training. Applicants must demonstrate expertise in PDMP implementation and operation, capacity to provide scalable and customizable training, and ability to measure outcomes effectively. No cost-sharing or matching is required for this opportunity, and applications must comply with eligibility and submission guidelines. Applications must be submitted through a two-step process. The first step involves submitting the SF-424 form via Grants.gov by March 18, 2025, at 11:59 p.m. Eastern Time. The second step requires the submission of a complete application in JustGrants by March 25, 2025, at 8:59 p.m. Eastern Time. The application must include a proposal narrative, budget detail form, and supporting documents such as resumes of key personnel and examples of previous work products. An active registration in SAM.gov is required to obtain a Unique Entity Identifier (UEI). Evaluation criteria for applications will include the relevance and effectiveness of the proposed training and technical assistance activities, the applicant’s capacity and competencies, and the cost-effectiveness of the budget. Additional considerations include geographic diversity and the potential impact of the project on reducing prescription drug misuse and diversion. Notifications of award decisions are expected by September 30, 2025. Post-award requirements include submitting regular financial and performance reports and maintaining close coordination with BJA to refine and implement approved work plans. Awardees must comply with federal civil rights laws, reporting standards, and other programmatic and administrative requirements. Applicants are encouraged to consult the OJP Application Resource Guide for detailed instructions and guidance. For further information, applicants may contact the OJP Response Center or access resources on the Grants.gov and JustGrants platforms.